AMPK inhibition sensitizes acute leukemia cells to BH3 mimetic-induced cell death.
Saved in:
| Title: | AMPK inhibition sensitizes acute leukemia cells to BH3 mimetic-induced cell death. |
|---|---|
| Authors: | Jia J; Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China.; University of Science and Technology of China, Hefei, 230026, China.; Hefei Cancer Hospital, Chinese Academy of Sciences, Hefei, 230031, China., Ji W; Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China.; University of Science and Technology of China, Hefei, 230026, China.; Hefei Cancer Hospital, Chinese Academy of Sciences, Hefei, 230031, China., Saliba AN; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, 55905, USA., Csizmar CM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, 55905, USA.; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, 55905, USA., Ye K; Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China.; Hefei Cancer Hospital, Chinese Academy of Sciences, Hefei, 230031, China., Hu L; Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China.; University of Science and Technology of China, Hefei, 230026, China.; Hefei Cancer Hospital, Chinese Academy of Sciences, Hefei, 230031, China., Peterson KL; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, 55905, USA., Schneider PA; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, 55905, USA., Meng XW; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, 55905, USA.; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, 55905, USA., Venkatachalam A; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, 55905, USA.; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, 55905, USA., Patnaik MM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, 55905, USA., Webster JA; Adult Leukemia Program, Sidney Kimmel Cancer Center at Johns Hopkins, Baltimore, MD, 21287, USA., Smith BD; Adult Leukemia Program, Sidney Kimmel Cancer Center at Johns Hopkins, Baltimore, MD, 21287, USA., Ghiaur G; Adult Leukemia Program, Sidney Kimmel Cancer Center at Johns Hopkins, Baltimore, MD, 21287, USA., Wu X; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, 55905, USA.; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA., Zhong J; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA., Pandey A; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, 55905, USA.; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA.; Manipal Academy of Higher Education, Manipal, 576104, Kamataka, India., Flatten KS; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, 55905, USA., Deng Q; Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China.; Hefei Cancer Hospital, Chinese Academy of Sciences, Hefei, 230031, China., Wang H; Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China.; Hefei Cancer Hospital, Chinese Academy of Sciences, Hefei, 230031, China., Kaufmann SH; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, 55905, USA. Kaufmann.Scott@Mayo.edu.; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, 55905, USA. Kaufmann.Scott@Mayo.edu.; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, 55905, USA. Kaufmann.Scott@Mayo.edu., Dai H; Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China. daih@cmpt.ac.cn.; Hefei Cancer Hospital, Chinese Academy of Sciences, Hefei, 230031, China. daih@cmpt.ac.cn.; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, 55905, USA. daih@cmpt.ac.cn. |
| Source: | Cell death and differentiation [Cell Death Differ] 2024 Apr; Vol. 31 (4), pp. 405-416. Date of Electronic Publication: 2024 Mar 27. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9437445 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5403 (Electronic) Linking ISSN: 13509047 NLM ISO Abbreviation: Cell Death Differ Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
